Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AUNA NASDAQ:FTRE NASDAQ:PNTG NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUNAAuna$4.32-1.5%$5.33$4.17▼$6.97$324.92M1.03307,341 shs508,388 shsFTREFortrea$13.22+0.6%$11.02$3.97▼$18.67$1.25B1.921.62 million shs924,137 shsPNTGThe Pennant Group$33.92-1.9%$32.01$21.73▼$37.54$1.20B1.28270,102 shs182,649 shsWGSGeneDx$47.310.0%$59.72$32.21▼$170.87$1.41B2.062.10 million shs1.09 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUNAAuna-3.01%-9.80%-16.62%-18.51%-36.83%FTREFortrea+0.61%-3.22%+25.90%+20.18%+214.76%PNTGThe Pennant Group-1.94%-4.59%+15.49%+4.95%+18.48%WGSGeneDx-0.04%+16.10%-32.25%-42.35%-30.20%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUNAAuna$4.32-1.5%$5.33$4.17▼$6.97$324.92M1.03307,341 shs508,388 shsFTREFortrea$13.22+0.6%$11.02$3.97▼$18.67$1.25B1.921.62 million shs924,137 shsPNTGThe Pennant Group$33.92-1.9%$32.01$21.73▼$37.54$1.20B1.28270,102 shs182,649 shsWGSGeneDx$47.310.0%$59.72$32.21▼$170.87$1.41B2.062.10 million shs1.09 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUNAAuna-3.01%-9.80%-16.62%-18.51%-36.83%FTREFortrea+0.61%-3.22%+25.90%+20.18%+214.76%PNTGThe Pennant Group-1.94%-4.59%+15.49%+4.95%+18.48%WGSGeneDx-0.04%+16.10%-32.25%-42.35%-30.20%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAUNAAuna 2.40Hold$7.3068.83% UpsideFTREFortrea 2.36Hold$17.2530.48% UpsidePNTGThe Pennant Group 2.75Moderate Buy$39.0014.98% UpsideWGSGeneDx 2.63Moderate Buy$96.43103.82% UpsideCurrent Analyst Ratings BreakdownLatest AUNA, FTRE, WGS, and PNTG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2026WGSGeneDx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/12/2026FTREFortrea MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$11.00 ➝ $13.005/8/2026PNTGThe Pennant Group Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$36.00 ➝ $42.005/8/2026PNTGThe Pennant Group Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$41.00 ➝ $42.005/8/2026PNTGThe Pennant Group Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$38.00 ➝ $41.005/7/2026PNTGThe Pennant Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B-) ➝ Hold (C+)5/7/2026FTREFortrea Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$14.005/6/2026FTREFortrea Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$19.005/6/2026FTREFortrea TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/6/2026FTREFortrea CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$16.00 ➝ $20.005/6/2026FTREFortrea Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$20.00(Data available from 5/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAUNAAuna$1.23B0.26$1.93 per share2.24$7.66 per share0.56FTREFortrea$2.71B0.46$9.94 per share1.33$5.56 per share2.38PNTGThe Pennant Group$947.71M1.24$1.26 per share26.99$11.20 per share3.03WGSGeneDx$427.54M3.29$2.29 per share20.65$8.56 per share5.53Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAUNAAuna$27.39M$0.2616.634.60N/A1.53%16.25%4.03%N/AFTREFortrea-$986.20M-$4.91N/A13.490.40-16.50%9.51%1.96%8/5/2026 (Estimated)PNTGThe Pennant Group$29.58M$0.8539.9125.312.322.96%10.07%4.23%8/5/2026 (Estimated)WGSGeneDx-$21.02M-$2.68N/A54.38N/A-17.58%9.15%5.21%8/4/2026 (Estimated)Latest AUNA, FTRE, WGS, and PNTG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q1 2026AUNAAuna$0.19$0.0510-$0.1390$0.03$320.54 million$336.84 million5/6/2026Q1 2026PNTGThe Pennant Group$0.31$0.32+$0.01$0.24$280.75 million$285.36 million5/5/2026Q1 2026FTREFortrea$0.03$0.16+$0.13-$0.25$628.51 million$636.50 million5/4/2026Q1 2026WGSGeneDx-$0.06-$0.28-$0.22-$2.16$112.46 million$102.25 million3/10/2026Q4 2025AUNAAuna$0.11$0.53+$0.42$1.33$1.08 billion$336.67 million2/26/2026Q4 2025FTREFortrea$0.16$0.09-$0.07-$0.35$665.22 million$660.50 million2/25/2026Q4 2025PNTGThe Pennant Group$0.31$0.34+$0.03$0.24$275.20 million$289.32 million2/23/2026Q4 2025WGSGeneDx$0.11$0.14+$0.03-$0.61$120.80 million$120.99 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAUNAAunaN/AN/AN/AN/AN/AFTREFortreaN/AN/AN/AN/AN/APNTGThe Pennant GroupN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAUNAAuna1.761.091.01FTREFortrea1.980.950.95PNTGThe Pennant Group0.421.191.19WGSGeneDx0.383.092.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAUNAAunaN/AFTREFortreaN/APNTGThe Pennant Group85.88%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipAUNAAunaN/AFTREFortrea0.38%PNTGThe Pennant Group6.90%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAUNAAuna15,25474.01 millionN/AN/AFTREFortrea14,30094.60 million94.24 millionOptionablePNTGThe Pennant Group9,70034.77 million32.37 millionOptionableWGSGeneDx1,30029.69 million20.90 millionOptionableAUNA, FTRE, WGS, and PNTG HeadlinesRecent News About These CompaniesAshland, GeneDX Holdings, and 3 more stocks see action from activist investorsMay 22 at 11:18 PM | msn.comGeneDx Holdings Earnings Estimates, EPS & Revenue | NASDAQ:WGSMay 22 at 1:17 PM | benzinga.comCasdin Capital, Llc Buys 140,000 Shares of GeneDx (NASDAQ:WGS) StockMay 22 at 4:21 AM | americanbankingnews.comCasdin Capital, Llc Buys 185,000 Shares of GeneDx (NASDAQ:WGS) StockMay 22 at 4:21 AM | americanbankingnews.comCasdin Capital, Llc Purchases 175,000 Shares of GeneDx (NASDAQ:WGS) StockMay 22 at 4:21 AM | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGSMay 21 at 3:33 PM | prnewswire.comGeneDx (NASDAQ:WGS) Stock Price Up 8.8% Following Insider Buying ActivityMay 21 at 11:58 AM | marketbeat.comCasdin Capital, Llc Acquires 140,000 Shares of GeneDx (NASDAQ:WGS) StockMay 21 at 7:16 AM | insidertrades.comGeneDx (NASDAQ:WGS) Director Casdin Capital, Llc Acquires 185,000 SharesMay 20 at 9:16 PM | marketbeat.comBarrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities FraudMay 20 at 9:30 AM | globenewswire.comGeneDx Holdings Corp. (WGS) Securities Fraud Investigation - Levi & KorsinskyMay 20 at 9:00 AM | prnewswire.comBragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. (NASDAQ:WGS) on Behalf of GeneDx Stockholders and Encourages Investors with Losses to Contact the FirmMay 19, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGSMay 19, 2026 | globenewswire.comWGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsMay 18, 2026 | globenewswire.comGeneDx (NASDAQ:WGS) and SBC Medical Group (NASDAQ:SBC) Head to Head AnalysisMay 18, 2026 | americanbankingnews.comFraud Investigation Opened: Levi & Korsinsky Investigates GeneDx Holdings Corp. (WGS) on Behalf of ShareholdersMay 17, 2026 | newsfilecorp.comNA Look At GeneDx Holdings (WGS) Valuation After Earnings Miss Guidance Cut And Securities InvestigationMay 17, 2026 | finance.yahoo.comKeith Meister Buys 165,000 Shares of GeneDx (NASDAQ:WGS) StockMay 17, 2026 | americanbankingnews.comKeith Meister Purchases 140,000 Shares of GeneDx (NASDAQ:WGS) StockMay 17, 2026 | americanbankingnews.comKeith Meister Acquires 46,273 Shares of GeneDx (NASDAQ:WGS) StockMay 17, 2026 | americanbankingnews.comComerica Bank Sells 29,753 Shares of GeneDx Holdings Corp. $WGSMay 17, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAUNA, FTRE, WGS, and PNTG Company DescriptionsAuna NYSE:AUNA$4.32 -0.07 (-1.50%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$4.30 -0.02 (-0.46%) As of 05/22/2026 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.Fortrea NASDAQ:FTRE$13.22 +0.08 (+0.61%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$13.30 +0.08 (+0.60%) As of 05/22/2026 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.The Pennant Group NASDAQ:PNTG$33.92 -0.67 (-1.94%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$33.92 -0.01 (-0.01%) As of 05/22/2026 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.GeneDx NASDAQ:WGS$47.31 -0.02 (-0.04%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$47.26 -0.05 (-0.10%) As of 05/22/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
